Dermatology Doctors in Norwalk, CT Accepting Medicare

10 Dermatology doctors found. Showing 1 - 10

Dr. Frank John Pinto Jr., MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 761 Main Ave, Suite 102, Norwalk, CT 06851 Phone: 203-810-4151    Fax: 203-810-4150

Ronald Steven Kahan, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 40 Cross St, Suite 340, Norwalk, CT 06851 Phone: 203-847-1500    Fax: 203-845-8764

Dr. Bruce S. Shames, M.D. Dermatology - Dermatopathology Medicare: Not Enrolled in Medicare Practice Location: 761 Main Ave, Suite 102, Norwalk, CT 06851 Phone: 203-810-4151    Fax: 203-810-4151

Stuart Howard Bender, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 761 Main Ave, Suite 102, Norwalk, CT 06851 Phone: 203-810-4151    Fax: 203-810-4150

Dr. Andrew M Herbst, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13 Park St, Norwalk, CT 06851 Phone: 212-772-9471

Dr. Charles L.g. Halasz, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 149 East Ave, Suite 20, Norwalk, CT 06851 Phone: 203-853-1874    Fax: 203-831-0007

Jennie B Nally, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 761 Main Ave, Suite 102, Norwalk, CT 06851 Phone: 203-810-4151    Fax: 203-810-4150

Debra Susan Weissman, MD Dermatology Medicare: Medicare Enrolled Practice Location: 40 Cross Street, Dermatology Center Pc Suite 340, Norwalk, CT 06851 Phone: 203-847-1500    Fax: 203-845-8764

Steven Andrew Kolenik Iii, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 761 Main Ave, Suite 102, Norwalk, CT 06851 Phone: 203-810-4151    Fax: 203-810-4150

Sang H Kim, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 761 Main Ave, Suite 102, Norwalk, CT 06851 Phone: 203-810-4151    Fax: 203-810-4150

News Archive

Winston announces Phase II study results of Dolorac for chronic migraine at Lazard Conference

Winston Pharmaceuticals, Inc. a specialty pharmaceutical company focused on developing and commercializing novel pain management therapies, announced the results of its Phase II study on its patented Dolorac Nasal Solution (doxepin 0.4%) for prophylaxis of chronic migraine at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.

6-month results of NovoStent's SAMBA trial for atherosclerotic disease in SFA and popliteal arteries

NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.

Celltrion receives approval for infliximab biosimilar antibody from Brazil's ANVISA

Hospira, Inc., a global leader in biosimilars, today announced that its partner, Celltrion – a global biopharmaceutical company – has received approval from ANVISA – the National Health Surveillance Agency in Brazil – for Remsima (infliximab), the first biosimilar monoclonal antibody approved for use in Brazil.

Melinda Gates discusses inclusion of contraception in global health agenda

In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Melinda gates, co-chair of the foundation, discusses including contraception on the global health agenda.

Study reveals a reduced risk of teenage eczema in breastfed babies

A new study, published in the Journal of the American Medical Association (JAMA) Pediatrics, indicates that the babies whose mothers were offered support to breastfeed completely for a prolonged period from birth have a 54% lesser eczema risk at the age of 16.

Read more Medical News

› Verified 2 days ago